HOLOGIC, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.42 USD | -0.30% |
|
-0.54% | +5.60% |
| May. 09 | Argus Adjusts Price Target on Hologic to $95 From $89 | MT |
| May. 06 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
Presenter SpeechTimothy Daley (Analysts)All right. Great. Perfect. Thanks, everybody. So welco...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows:
- molecular diagnostics (46.7%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;
- breast health (35.5%): digital mammography and breast biopsy solutions and systems;
- gynecological surgery (15%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;
- bone health (2.8%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.
Net sales break down by source of revenue between sales of products (81.4%) and services (18.6%).
Net sales are distributed geographically as follows: the United States (75.9%), Europe (12.9%), Asia/Pacific (6.3%) and other (4.9%).
Calendar
2024-07-23
- Q3 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
75.65
USD
Average target price
85
USD
Spread / Average Target
+12.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.60% | 17.65B | |
| +13.08% | 227B | |
| +13.58% | 192B | |
| +18.03% | 136B | |
| +28.33% | 108B | |
| +1.67% | 64.07B | |
| +17.66% | 52.1B | |
| +7.04% | 51.87B | |
| +10.88% | 44.33B | |
| +6.31% | 36.75B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Transcript : Hologic, Inc. Presents at Wells Fargo Securities Healthcare Conference 2023, Sep-06-2023 09
